In mass tort litigation, where every lead matters, having a trusted partner is paramount. Alert is your dedicated ally, providing 24/7/365 legal operational support services meticulously tailored to your needs. Our comprehensive services include 24-hour answering, booking, scheduling, intake questionnaire assistance, and case status updates. We’re your strategic advantage in streamlining mass tort answering services and maximizing conversion rates.
A Closer Look at Our Services
With Alert, your firm gains access to a powerhouse of capabilities:
- 24-Hour Answering: Our round-the-clock service ensures no lead goes unanswered, allowing you to capture inquiries at any hour and stay ahead in the competitive mass tort landscape.
- Booking and Scheduling: Seamlessly manage appointments and consultations with our booking and scheduling services, optimizing your workflow for efficiency.
- Intake Questionnaire Assistance: Accurate intake questionnaires are pivotal in mass tort cases. Our skilled intake specialists follow up with respondents to reduce drop-off rates, ensuring that critical information is captured efficiently.
- Case Status Updates: Transparency and client experience are key. We partner with Case Status to facilitate updates, enhancing trust and communication with your clients.
The Ozempic and Mounjaro Lawsuit: Unveiling Allegations and Implications
In a recent development, a personal injury law firm has launched a lawsuit against pharmaceutical giants Novo Nordisk and Eli Lilly and Co., the manufacturers of Ozempic and Mounjaro.1 This lawsuit centers around the alleged severe side effects of these diabetes drugs, which are renowned for their role in aiding weight loss. The crux of the matter is the claim that these drugs may cause gastroparesis—a condition characterized by stomach paralysis.
The Key Parties Involved
The reputable firm Morgan & Morgan spearheaded the lawsuit, with Paul Pennock and Jonathan Sedgh serving as lead attorneys. Their lawsuit is rooted in a “failure to warn” basis, asserting that there is sufficient evidence to substantiate the claim that these drugs are causing severe health issues. The defendants in this case are Novo Nordisk and Eli Lilly and Co., the manufacturers of Ozempic and Mounjaro, respectively.2
Allegations and Potential Consequences
The core allegation is that despite their widespread use, Ozempic and Mounjaro may contribute to the occurrence of gastroparesis. This condition, which slows or halts food movement from the stomach to the small intestine, can be debilitating. The implications of this lawsuit extend beyond the initial plaintiff, a 44-year-old woman from Louisiana who reportedly experienced severe health problems, including violent vomiting episodes. The lawsuit has garnered attention due to its potential impact on individuals using these medications. Currently, the plaintiff seeks financial compensation, though an official diagnosis of gastroparesis has not been confirmed.
Take Control of Your Mass Tort Campaign with Alert
As you navigate the intricacies of mass tort litigation, don’t let unanswered inquiries hinder your progress. Alert is here to empower your campaign, streamline your processes, and ensure that every lead is noticed. Secure your competitive edge and provide unmatched support to your clients. It’s time to elevate your mass tort services—schedule a call with Alert today.
Sources:
1.CBS News. Ozempic, Mounjaro manufacturers sued over claims of “stomach paralysis” side effects.
2.Drugwatch. Ozempic Lawsuit.
